[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1165 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
H. RES. 1165

   Expressing support for the designation of April as ``Co-Occurring 
                      Disorders Awareness Month''.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 20, 2024

 Mr. LaLota submitted the following resolution; which was referred to 
                  the Committee on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION


 
   Expressing support for the designation of April as ``Co-Occurring 
                      Disorders Awareness Month''.

Whereas a co-occurring disorder, also known as dual diagnosis, is the condition 
        of having a mental illness and a comorbid substance use disorder;
Whereas, according to the Substance Abuse and Mental Health Services 
        Administration's 2022 National Survey on Drug Use and Health, 
        approximately 21,500,000 adults in the United States have a co-occurring 
        disorder;
Whereas people with mental illness are more likely to experience a substance use 
        disorder than those not affected by a mental illness;
Whereas no specific combinations of mental and substance use disorders are 
        defined uniquely as co-occurring disorders;
Whereas the presence of two or more disorders can complicate diagnosis and 
        treatment;
Whereas integrating both screening and treatment for mental and substance use 
        disorders leads to a better quality of care and health outcomes for 
        those living with co-occurring disorders by treating the whole person;
Whereas increased awareness leads to earlier detection; and
Whereas early detection and integrated treatment can together improve outcomes 
        and quality of life for people with co-occurring disorders: Now, 
        therefore, be it
    Resolved, That the House of Representatives--
            (1) expresses support for the designation of ``Co-Occurring 
        Disorders Awareness Month''; and
            (2) recognizes the importance of--
                    (A) improving awareness;
                    (B) advancing research; and
                    (C) developing new treatments and diagnostics for 
                co-occurring disorders.
                                 <all>